id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-351349-ypaevb8b	van Koningsbruggen-Rietschel, Silke	SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network	2020-08-07		.txt	text/plain	894	38	43	We believe that disease specific CTNs are an effective way for rare disease clinical trial sites to learn from each other and overcome obstacles such as the current pandemic, while working towards the goals of effective treatments for rare diseases. key: cord-351349-ypaevb8b authors: van Koningsbruggen-Rietschel, Silke; Dunlevy, Fiona; Bulteel, Veerle; Downey, Damian; Dupont, Lieven title: SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network date: 2020-08-07 journal: Eur Respir J DOI: 10.1183/13993003.02114-2020 sha: doc_id: 351349 cord_uid: ypaevb8b Rare disease patients may suffer delayed access to new drugs as SARS-CoV-2 is disrupting clinical trials.	cache/cord-351349-ypaevb8b.txt	txt/cord-351349-ypaevb8b.txt
